Anika Therapeutics reported $31793849155.9B in Stock for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acorda Therapeutics ACOR:US $ 28.68M 0M
Adamas Pharmaceuticals ADMS:US 7.29M 440K
Arrowhead Research ARWR:US 0 0
Clovis Oncology CLVS:US $ 22.17M 8.55M
Flexion Therapeutics FLXN:US $ 17.89M 2.5M
Halozyme Therapeutics HALO:US $ 60.75M 3.05M
Heron Therapeutics HRTX:US $ 42.63M 0.72M
Integra Lifesciences IART:US $ 328.05M 17.93M
Intrexon XON:US $ 11.36M 0M
Johnson & Johnson JNJ:US $ 9952M 608M
Karyopharm Therapeutics KPTI:US $ 3.11M 470K
Ligand Pharmaceuticals LGND:US $ 36.93M 10.44M
Peregrine Pharmaceuticals PPHM:US $ 11.95M 0M
Rigel Pharmaceuticals RIGL:US $ 1.64M 0M
Stryker SYK:US $ 3473M 21M
Surmodics SRDX:US $ 6.31M 0.05M
Veracyte VCYT:US $ 4.66M 0.2M